Radiologists' use of CAD systems as a second reader to catch missed nodules during lung cancer screening.
Computer-aided detection (CAD) systems can be a useful second reader back-up for radiologists screening for lung cancer, according to an article published in Radiology.
Researchers from the Icahn School of Medicine at Mount Sinai in New York City and Cornell University, Ithaca, NY, sought to determine if CAD was a useful tool to help radiologists detect lung cancers during early imaging.
The researchers obtained images of 50 lung cancers that manifested as a solid nodule on CT scans in annual rounds of screening (time 1). Time zero was when all cancers were missed. Four CAD systems (CAD 1, CAD 2, CAD 3, and CAD 4) were compared to the radiologists’ findings. Two radiologists assessed the CAD-system detected nodules, and they also documented the solid nodules that were not detected by the CAD system.
The average diameter of the 50 cancers at time 0 and time 1 was 4.8 mm and 11.4 mm, respectively. The results showed that the CAD systems detected at least 56% of the nodules.
The number of CAD-system–detected nodules that were rejected per CT scan for CAD systems 1 to 4 at time 0 was 7.4, 1.7, 0.6, and 4.5 respectively.
The researchers concluded that most of the lung cancers, up to 70%, that had not been detected by the radiologist upon screening were detected by the CAD systems, however, about 20% of the nodules that were detected by radiologists were not picked up by the CAD system.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.